Genpharmasec Limited (BOM:531592)

Genpharmasec Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 6, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,131	1,009	1,235	861	1,523	2,218
Market Cap Growth	-18.31%	-18.31%	43.41%	-43.45%	-31.34%	-21.03%
Enterprise Value	1,133	1,021	1,221	805	1,447	2,067
Last Close Price	2.12	1.89	2.23	1.87	3.30	4.81
PE Ratio	91.90	81.93	-	76.55	-	176.37
PS Ratio	3.36	2.99	4.06	3.38	5.57	10.41
PB Ratio	1.73	1.55	1.91	5.62	9.91	10.73
P/TBV Ratio	1.74	1.55	1.92	5.62	9.91	10.73
P/OCF Ratio	37.77	33.67	-	-	-	-
EV/Sales Ratio	3.36	3.03	4.01	3.15	5.30	9.70
EV/EBITDA Ratio	-	1587.24	5926.15	300.20	-	173.03
EV/EBIT Ratio	-	-	31302.23	324.00	-	174.86
EV/FCF Ratio	-41.80	-	-	-	-	-
Debt / Equity Ratio	0.08	0.08	0.06	0.20	-	-
Debt / EBITDA Ratio	82.19	82.19	84.54	11.50	-	-
Asset Turnover	0.45	0.45	0.67	1.23	1.11	0.81
Inventory Turnover	3.75	3.75	2.93	2.75	4.22	4.79
Quick Ratio	1.92	1.92	11.45	4.54	2.02	3.05
Current Ratio	2.86	2.86	15.16	9.17	3.43	3.74
Return on Equity (ROE)	1.90%	1.90%	-0.42%	7.33%	-1.16%	6.33%
Return on Assets (ROA)	-0.62%	-0.62%	0.01%	0.75%	-1.35%	2.81%
Return on Capital (ROIC)	-0.67%	-0.67%	0.01%	0.92%	-1.86%	3.72%
Return on Capital Employed (ROCE)	-	-	0.00%	1.40%	-	5.70%
Earnings Yield	1.09%	1.22%	-0.10%	1.31%	-0.14%	0.57%
FCF Yield	-2.39%	-2.69%	-2.40%	-3.57%	-1.59%	-0.97%
Buyback Yield / Dilution	-	-	-10.96%	-	-2.06%	46.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.